바이오테크 보도자료
-
- LSK Global PS Adopts Veeva Vault Clinical Applications to Streamline Global Trial Processes
- Veeva Systems (NYSE: VEEV) announced that LSK Global Pharma Services Co. Ltd, a leading Korean contract research organization (CRO), has adopted Veeva Vault eTMF, Veeva Vault CTMS, and Veeva SiteVault Free. With Veeva Vault Clinical applications, ...
- 2021년 03월 08일
-
- COVID-19 Vaccine Adjuvant Potentials of Nichi Glucan Dietary Supplement From Japan
- ß- glucan produced by AFO-202 strain of black yeast Aureobasidium Pullulans (Nichi Glucan), having immune enhancement potentials through all major pathways, has been recommended worth clinical studies for validation as a vaccine adjuvant in COVID-...
- 2021년 03월 05일
-
- PierianDx Announces the Appointment of Lindsay Mateo as Chief Business Officer
- PierianDx, the global leader in clinical genomics knowledge, today announced the appointment of Lindsay Mateo as Chief Business Officer, effective immediately. In her new role, Ms. Mateo will reinforce the company’s position as the leading provide...
- 2021년 03월 04일
-
- Rimini Street Announces Fiscal Fourth Quarter and Annual 2020 Financial Results
- Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesforce partner, today announced results for the fourth quar...
- 2021년 03월 04일
-
- Vifor Pharma delivers strong full year results 2020 with an EBITDA of 576 million Swiss Francs representing over 29% growth[1]
- Regulatory News: Vifor Pharma Group reported stable net sales and a continued strong increase in profitability in 2020, despite challenges to patient access from COVID-19 and the impact of a much stronger Swiss franc against the US dollar. FINANCI...
- 2021년 03월 03일
-
- Takeda to Divest Four Diabetes Products in Japan to Teijin Pharma Limited
- Takeda Pharmaceutical Company Limited (TOKYO:4502) (NYSE:TAK) (“Takeda”) today announced that it has entered into an agreement to transfer the assets, marketing rights and, eventually, marketing authorization associated with a portfolio of select ...
- 2021년 03월 02일
-
- Illuminating the Heroes of Rare Diseases
- With a mission of empowering the rare disease community, Illumina has today partnered with medical researchers and families to highlight the importance of genomic sequencing and to shine the spotlight on the 300 million people worldwide living wit...
- 2021년 03월 02일
-
- Saint-Gobain Life Sciences Introduces Highly Efficient Cell Culture Bags for T Cell Expansion
- Saint-Gobain Life Sciences, an industry leader in material science-based solutions for cell and gene therapy manufacturing, today launched a new cell culture bag designed specifically for T cell derived therapies. T cell based therapies are revolu...
- 2021년 02월 26일
-
- Walkinshaw Andretti United Partners with Proven 3D Printing Technology Ready for 2021 Supercar Championship
- From the Sandown 500 and Bathurst 1000 to the Supercars Championship, the Walkinshaw Andretti United (WAU) Racing team has stood on the podium every season since their debut, the team continues to seek ways to improve both on-track and off-track. ...
- 2021년 02월 26일
-
- Takeda Provides Updates on Phase 1/2 Clinical Trials of Novavax’ and Moderna’s COVID-19 Vaccine Candidates in Japan
- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) announced today that the first subject was dosed in its Phase 1/2 immunogenicity and safety study of Novavax’ COVID-19 vaccine candidate (TAK-019) in Japan. Earlier this month, Takeda compl...
- 2021년 02월 25일
-
- Yokogawa and ICQ Consultants Enter Into Partnership Agreement for Biopharmaceutical Business
- Yokogawa Electric Corporation (TOKYO:6841) (Yokogawa) and Integrated Commissioning and Qualification Consultants, Corp. (ICQ Consultants) of Southborough announce that they have entered into a partnership agreement under which ICQ Consultants will...
- 2021년 02월 24일
전시회
